A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma

NCT00659659 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MEDI-563
DRUG: MEDI-563
OTHER: Placebo Comp.
OTHER: Placebo

Sponsor

MedImmune LLC